Pre-order Enquiry
Request Free Sample
Global Transdermal/Transmucosal Drug Delivery System Market Research Report 2020
SKU ID : QYR-15060951 | Publishing Date : 08-Jan-2020 | No. of pages : 122
Detailed TOC of Global Transdermal/Transmucosal Drug Delivery System Market Research Report 2020
Table of Contents1 Transdermal/Transmucosal Drug Delivery System Market Overview
1.1 Product Overview and Scope of Transdermal/Transmucosal Drug Delivery System
1.2 Transdermal/Transmucosal Drug Delivery System Segment by Type
1.2.1 Global Transdermal/Transmucosal Drug Delivery System Sales Growth Rate Comparison by Type (2021-2026)
1.2.2 Transdermal Drug Delivery System
1.2.3 Transmucosal Drug Delivery System
1.3 Transdermal/Transmucosal Drug Delivery System Segment by Application
1.3.1 Transdermal/Transmucosal Drug Delivery System Sales Comparison by Application: 2020 VS 2026
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Transdermal/Transmucosal Drug Delivery System Market Size Estimates and Forecasts
1.4.1 Global Transdermal/Transmucosal Drug Delivery System Revenue 2015-2026
1.4.2 Global Transdermal/Transmucosal Drug Delivery System Sales 2015-2026
1.4.3 Transdermal/Transmucosal Drug Delivery System Market Size by Region: 2020 Versus 2026
2 Global Transdermal/Transmucosal Drug Delivery System Market Competition by Manufacturers
2.1 Global Transdermal/Transmucosal Drug Delivery System Sales Market Share by Manufacturers (2015-2020)
2.2 Global Transdermal/Transmucosal Drug Delivery System Revenue Share by Manufacturers (2015-2020)
2.3 Global Transdermal/Transmucosal Drug Delivery System Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Transdermal/Transmucosal Drug Delivery System Manufacturing Sites, Area Served, Product Type
2.5 Transdermal/Transmucosal Drug Delivery System Market Competitive Situation and Trends
2.5.1 Transdermal/Transmucosal Drug Delivery System Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Transdermal/Transmucosal Drug Delivery System Players (Opinion Leaders)
3 Transdermal/Transmucosal Drug Delivery System Retrospective Market Scenario by Region
3.1 Global Transdermal/Transmucosal Drug Delivery System Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Transdermal/Transmucosal Drug Delivery System Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Transdermal/Transmucosal Drug Delivery System Market Facts & Figures by Country
3.3.1 North America Transdermal/Transmucosal Drug Delivery System Sales by Country
3.3.2 North America Transdermal/Transmucosal Drug Delivery System Sales by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Transdermal/Transmucosal Drug Delivery System Market Facts & Figures by Country
3.4.1 Europe Transdermal/Transmucosal Drug Delivery System Sales by Country
3.4.2 Europe Transdermal/Transmucosal Drug Delivery System Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Transdermal/Transmucosal Drug Delivery System Market Facts & Figures by Region
3.5.1 Asia Pacific Transdermal/Transmucosal Drug Delivery System Sales by Region
3.5.2 Asia Pacific Transdermal/Transmucosal Drug Delivery System Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Transdermal/Transmucosal Drug Delivery System Market Facts & Figures by Country
3.6.1 Latin America Transdermal/Transmucosal Drug Delivery System Sales by Country
3.6.2 Latin America Transdermal/Transmucosal Drug Delivery System Sales by Country
3.6.3 Mexico
3.6.3 Brazil
3.6.3 Argentina
3.7 Middle East and Africa Transdermal/Transmucosal Drug Delivery System Market Facts & Figures by Country
3.7.1 Middle East and Africa Transdermal/Transmucosal Drug Delivery System Sales by Country
3.7.2 Middle East and Africa Transdermal/Transmucosal Drug Delivery System Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Transdermal/Transmucosal Drug Delivery System Historic Market Analysis by Type
4.1 Global Transdermal/Transmucosal Drug Delivery System Sales Market Share by Type (2015-2020)
4.2 Global Transdermal/Transmucosal Drug Delivery System Revenue Market Share by Type (2015-2020)
4.3 Global Transdermal/Transmucosal Drug Delivery System Price Market Share by Type (2015-2020)
4.4 Global Transdermal/Transmucosal Drug Delivery System Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Global Transdermal/Transmucosal Drug Delivery System Historic Market Analysis by Application
5.1 Global Transdermal/Transmucosal Drug Delivery System Sales Market Share by Application (2015-2020)
5.2 Global Transdermal/Transmucosal Drug Delivery System Revenue Market Share by Application (2015-2020)
5.3 Global Transdermal/Transmucosal Drug Delivery System Price by Application (2015-2020)
6 Company Profiles and Key Figures in Transdermal/Transmucosal Drug Delivery System Business
6.1 3M
6.1.1 Corporation Information
6.1.2 3M Description, Business Overview and Total Revenue
6.1.3 3M Transdermal/Transmucosal Drug Delivery System Sales, Revenue and Gross Margin (2015-2020)
6.1.4 3M Products Offered
6.1.5 3M Recent Development
6.2 Antares Pharma
6.2.1 Antares Pharma Transdermal/Transmucosal Drug Delivery System Production Sites and Area Served
6.2.2 Antares Pharma Description, Business Overview and Total Revenue
6.2.3 Antares Pharma Transdermal/Transmucosal Drug Delivery System Sales, Revenue and Gross Margin (2015-2020)
6.2.4 Antares Pharma Products Offered
6.2.5 Antares Pharma Recent Development
6.3 Aveva Drug Delivery Systems
6.3.1 Aveva Drug Delivery Systems Transdermal/Transmucosal Drug Delivery System Production Sites and Area Served
6.3.2 Aveva Drug Delivery Systems Description, Business Overview and Total Revenue
6.3.3 Aveva Drug Delivery Systems Transdermal/Transmucosal Drug Delivery System Sales, Revenue and Gross Margin (2015-2020)
6.3.4 Aveva Drug Delivery Systems Products Offered
6.3.5 Aveva Drug Delivery Systems Recent Development
6.4 Corium International
6.4.1 Corium International Transdermal/Transmucosal Drug Delivery System Production Sites and Area Served
6.4.2 Corium International Description, Business Overview and Total Revenue
6.4.3 Corium International Transdermal/Transmucosal Drug Delivery System Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Corium International Products Offered
6.4.5 Corium International Recent Development
6.5 DURECT
6.5.1 DURECT Transdermal/Transmucosal Drug Delivery System Production Sites and Area Served
6.5.2 DURECT Description, Business Overview and Total Revenue
6.5.3 DURECT Transdermal/Transmucosal Drug Delivery System Sales, Revenue and Gross Margin (2015-2020)
6.5.4 DURECT Products Offered
6.5.5 DURECT Recent Development
6.6 Pantec Biosolutions
6.6.1 Pantec Biosolutions Transdermal/Transmucosal Drug Delivery System Production Sites and Area Served
6.6.2 Pantec Biosolutions Description, Business Overview and Total Revenue
6.6.3 Pantec Biosolutions Transdermal/Transmucosal Drug Delivery System Sales, Revenue and Gross Margin (2015-2020)
6.6.4 Pantec Biosolutions Products Offered
6.6.5 Pantec Biosolutions Recent Development
6.7 Tapemark
6.6.1 Tapemark Transdermal/Transmucosal Drug Delivery System Production Sites and Area Served
6.6.2 Tapemark Description, Business Overview and Total Revenue
6.6.3 Tapemark Transdermal/Transmucosal Drug Delivery System Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Tapemark Products Offered
6.7.5 Tapemark Recent Development
6.8 Tesa Labtec
6.8.1 Tesa Labtec Transdermal/Transmucosal Drug Delivery System Production Sites and Area Served
6.8.2 Tesa Labtec Description, Business Overview and Total Revenue
6.8.3 Tesa Labtec Transdermal/Transmucosal Drug Delivery System Sales, Revenue and Gross Margin (2015-2020)
6.8.4 Tesa Labtec Products Offered
6.8.5 Tesa Labtec Recent Development
6.9 Mylan
6.9.1 Mylan Transdermal/Transmucosal Drug Delivery System Production Sites and Area Served
6.9.2 Mylan Description, Business Overview and Total Revenue
6.9.3 Mylan Transdermal/Transmucosal Drug Delivery System Sales, Revenue and Gross Margin (2015-2020)
6.9.4 Mylan Products Offered
6.9.5 Mylan Recent Development
6.10 Teva
6.10.1 Teva Transdermal/Transmucosal Drug Delivery System Production Sites and Area Served
6.10.2 Teva Description, Business Overview and Total Revenue
6.10.3 Teva Transdermal/Transmucosal Drug Delivery System Sales, Revenue and Gross Margin (2015-2020)
6.10.4 Teva Products Offered
6.10.5 Teva Recent Development
6.11 Zosano Pharma
6.11.1 Zosano Pharma Transdermal/Transmucosal Drug Delivery System Production Sites and Area Served
6.11.2 Zosano Pharma Transdermal/Transmucosal Drug Delivery System Description, Business Overview and Total Revenue
6.11.3 Zosano Pharma Transdermal/Transmucosal Drug Delivery System Sales, Revenue and Gross Margin (2015-2020)
6.11.4 Zosano Pharma Products Offered
6.11.5 Zosano Pharma Recent Development
7 Transdermal/Transmucosal Drug Delivery System Manufacturing Cost Analysis
7.1 Transdermal/Transmucosal Drug Delivery System Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Transdermal/Transmucosal Drug Delivery System
7.4 Transdermal/Transmucosal Drug Delivery System Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Transdermal/Transmucosal Drug Delivery System Distributors List
8.3 Transdermal/Transmucosal Drug Delivery System Customers
9 Market Dynamics
9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis
10 Global Market Forecast
10.1 Global Transdermal/Transmucosal Drug Delivery System Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Transdermal/Transmucosal Drug Delivery System by Type (2021-2026)
10.1.2 Global Forecasted Revenue of Transdermal/Transmucosal Drug Delivery System by Type (2021-2026)
10.2 Transdermal/Transmucosal Drug Delivery System Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Transdermal/Transmucosal Drug Delivery System by Application (2021-2026)
10.2.2 Global Forecasted Revenue of Transdermal/Transmucosal Drug Delivery System by Application (2021-2026)
10.3 Transdermal/Transmucosal Drug Delivery System Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Transdermal/Transmucosal Drug Delivery System by Region (2021-2026)
10.3.2 Global Forecasted Revenue of Transdermal/Transmucosal Drug Delivery System by Region (2021-2026)
10.4 North America Transdermal/Transmucosal Drug Delivery System Estimates and Projections (2021-2026)
10.5 Europe Transdermal/Transmucosal Drug Delivery System Estimates and Projections (2021-2026)
10.6 Asia Pacific Transdermal/Transmucosal Drug Delivery System Estimates and Projections (2021-2026)
10.7 Latin America Transdermal/Transmucosal Drug Delivery System Estimates and Projections (2021-2026)
10.8 Middle East and Africa Transdermal/Transmucosal Drug Delivery System Estimates and Projections (2021-2026)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Figures, Tables and Charts Available in Global Transdermal/Transmucosal Drug Delivery System Market Research Report 2020
List of TablesTable 1. Global Transdermal/Transmucosal Drug Delivery System Sales (K Units) Growth Rate Comparison by Type (2015-2026)
Table 2. Global Transdermal/Transmucosal Drug Delivery System Sales (K Units) Comparison by Application: 2020 VS 2026
Table 3. Global Transdermal/Transmucosal Drug Delivery System Market Size by Type (K Units) (US$ Million) (2020 VS 2026)
Table 4. Global Key Transdermal/Transmucosal Drug Delivery System Manufacturers Covered in This Study
Table 5. Global Transdermal/Transmucosal Drug Delivery System Sales (K Units) by Manufacturers (2015-2020)
Table 6. Global Transdermal/Transmucosal Drug Delivery System Sales Share by Manufacturers (2015-2020)
Table 7. Global Transdermal/Transmucosal Drug Delivery System Revenue (Million USD) by Manufacturers (2015-2020)
Table 8. Global Transdermal/Transmucosal Drug Delivery System Revenue Share by Manufacturers (2015-2020)
Table 9. Global Market Transdermal/Transmucosal Drug Delivery System Average Price (USD/Unit) of Key Manufacturers (2015-2020)
Table 10. Manufacturers Transdermal/Transmucosal Drug Delivery System Sales Sites and Area Served
Table 11. Manufacturers Transdermal/Transmucosal Drug Delivery System Product Types
Table 12. Global Transdermal/Transmucosal Drug Delivery System Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Transdermal/Transmucosal Drug Delivery System by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Transdermal/Transmucosal Drug Delivery System as of 2019)
Table 14.Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Main Points Interviewed from Key Transdermal/Transmucosal Drug Delivery System Players
Table 16. Global Transdermal/Transmucosal Drug Delivery System Sales (K Units) by Region (2015-2020)
Table 17. Global Transdermal/Transmucosal Drug Delivery System Sales Market Share by Region (2015-2020)
Table 18. Global Transdermal/Transmucosal Drug Delivery System Revenue (Million US$) by Region (2015-2020)
Table 19. Global Transdermal/Transmucosal Drug Delivery System Revenue Market Share by Region (2015-2020)
Table 20. North America Transdermal/Transmucosal Drug Delivery System Sales by Country (2015-2020) (K Units)
Table 21. North America Transdermal/Transmucosal Drug Delivery System Sales Market Share by Country (2015-2020)
Table 22. North America Transdermal/Transmucosal Drug Delivery System Revenue by Country (2015-2020) (US$ Million)
Table 23. North America Transdermal/Transmucosal Drug Delivery System Revenue Market Share by Country (2015-2020)
Table 24. Europe Transdermal/Transmucosal Drug Delivery System Sales by Country (2015-2020) (K Units)
Table 25. Europe Transdermal/Transmucosal Drug Delivery System Sales Market Share by Country (2015-2020)
Table 26. Europe Transdermal/Transmucosal Drug Delivery System Revenue by Country (2015-2020) (US$ Million)
Table 27. Europe Transdermal/Transmucosal Drug Delivery System Revenue Market Share by Country (2015-2020)
Table 28. Asia Pacific Transdermal/Transmucosal Drug Delivery System Sales by Region (2015-2020) (K Units)
Table 29. Asia Pacific Transdermal/Transmucosal Drug Delivery System Sales Market Share by Region (2015-2020)
Table 30. Asia Pacific Transdermal/Transmucosal Drug Delivery System Revenue by Region (2015-2020) (US$ Million)
Table 31. Asia Pacific Transdermal/Transmucosal Drug Delivery System Revenue Market Share by Region (2015-2020)
Table 32. Latin America Transdermal/Transmucosal Drug Delivery System Sales by Country (2015-2020) (K Units)
Table 33. Latin America Transdermal/Transmucosal Drug Delivery System Sales Market Share by Country (2015-2020)
Table 34. Latin America Transdermal/Transmucosal Drug Delivery System Revenue by Country (2015-2020) (US$ Million)
Table 35. Latin America Transdermal/Transmucosal Drug Delivery System Revenue Market Share by Country (2015-2020)
Table 36. Middle East and Africa Transdermal/Transmucosal Drug Delivery System Sales by Country (2015-2020) (K Units)
Table 37. Middle East and Africa Transdermal/Transmucosal Drug Delivery System Sales Market Share by Country (2015-2020)
Table 38. Middle East and Africa Transdermal/Transmucosal Drug Delivery System Revenue by Country (2015-2020) (US$ Million)
Table 39. Middle East and Africa Transdermal/Transmucosal Drug Delivery System Revenue Market Share by Country (2015-2020)
Table 40. Global Transdermal/Transmucosal Drug Delivery System Sales (K Units) by Type (2015-2020)
Table 41. Global Transdermal/Transmucosal Drug Delivery System Sales Share by Type (2015-2020)
Table 42. Global Transdermal/Transmucosal Drug Delivery System Revenue (Million US$) by Type (2015-2020)
Table 43. Global Transdermal/Transmucosal Drug Delivery System Revenue Share by Type (2015-2020)
Table 44. Global Transdermal/Transmucosal Drug Delivery System Price (USD/Unit) by Type (2015-2020)
Table 45. Global Transdermal/Transmucosal Drug Delivery System Sales (K Units) by Application (2015-2020)
Table 46. Global Transdermal/Transmucosal Drug Delivery System Sales Market Share by Application (2015-2020)
Table 47. Global Transdermal/Transmucosal Drug Delivery System Sales Growth Rate by Application (2015-2020)
Table 48. 3M Transdermal/Transmucosal Drug Delivery System Corporation Information
Table 49. 3M Description and Business Overview
Table 50. 3M Transdermal/Transmucosal Drug Delivery System Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 51. 3M Main Product
Table 52. 3M Recent Development
Table 53. Antares Pharma Transdermal/Transmucosal Drug Delivery System Corporation Information
Table 54. Antares Pharma Corporation Information
Table 55. Antares Pharma Transdermal/Transmucosal Drug Delivery System Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 56. Antares Pharma Main Product
Table 57. Antares Pharma Recent Development
Table 58. Aveva Drug Delivery Systems Transdermal/Transmucosal Drug Delivery System Corporation Information
Table 59. Aveva Drug Delivery Systems Corporation Information
Table 60. Aveva Drug Delivery Systems Transdermal/Transmucosal Drug Delivery System Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 61. Aveva Drug Delivery Systems Main Product
Table 62. Aveva Drug Delivery Systems Recent Development
Table 63. Corium International Transdermal/Transmucosal Drug Delivery System Corporation Information
Table 64. Corium International Corporation Information
Table 65. Corium International Transdermal/Transmucosal Drug Delivery System Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 66. Corium International Main Product
Table 67. Corium International Recent Development
Table 68. DURECT Transdermal/Transmucosal Drug Delivery System Corporation Information
Table 69. DURECT Corporation Information
Table 70. DURECT Transdermal/Transmucosal Drug Delivery System Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 71. DURECT Main Product
Table 72. DURECT Recent Development
Table 73. Pantec Biosolutions Transdermal/Transmucosal Drug Delivery System Corporation Information
Table 74. Pantec Biosolutions Corporation Information
Table 75. Pantec Biosolutions Transdermal/Transmucosal Drug Delivery System Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 76. Pantec Biosolutions Main Product
Table 77. Pantec Biosolutions Recent Development
Table 78. Tapemark Transdermal/Transmucosal Drug Delivery System Corporation Information
Table 79. Tapemark Corporation Information
Table 80. Tapemark Transdermal/Transmucosal Drug Delivery System Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 81. Tapemark Main Product
Table 82. Tapemark Recent Development
Table 83. Tesa Labtec Transdermal/Transmucosal Drug Delivery System Corporation Information
Table 84. Tesa Labtec Corporation Information
Table 85. Tesa Labtec Transdermal/Transmucosal Drug Delivery System Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 86. Tesa Labtec Main Product
Table 87. Tesa Labtec Recent Development
Table 88. Mylan Transdermal/Transmucosal Drug Delivery System Corporation Information
Table 89. Mylan Corporation Information
Table 90. Mylan Transdermal/Transmucosal Drug Delivery System Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 91. Mylan Main Product
Table 92. Mylan Recent Development
Table 93. Teva Transdermal/Transmucosal Drug Delivery System Corporation Information
Table 94. Teva Corporation Information
Table 95. Teva Transdermal/Transmucosal Drug Delivery System Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 96. Teva Main Product
Table 97. Teva Recent Development
Table 98. Zosano Pharma Transdermal/Transmucosal Drug Delivery System Corporation Information
Table 99. Zosano Pharma Corporation Information
Table 100. Zosano Pharma Transdermal/Transmucosal Drug Delivery System Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 101. Zosano Pharma Main Product
Table 102. Zosano Pharma Recent Development
Table 103. Sales Base and Market Concentration Rate of Raw Material
Table 104. Key Suppliers of Raw Materials
Table 105. Transdermal/Transmucosal Drug Delivery System Distributors List
Table 106. Transdermal/Transmucosal Drug Delivery System Customers List
Table 107. Market Key Trends
Table 108. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 109. Key Challenges
Table 110. Global Transdermal/Transmucosal Drug Delivery System Sales (K Units) Forecast by Type (2021-2026)
Table 111. Global Transdermal/Transmucosal Drug Delivery System Sales Market Share Forecast by Type (2021-2026)
Table 112. Global Transdermal/Transmucosal Drug Delivery System Revenue (Million US$) Forecast by Type (2021-2026)
Table 113. Global Transdermal/Transmucosal Drug Delivery System Revenue (Million US$) Market Share Forecast by Type (2021-2026)
Table 114. Global Transdermal/Transmucosal Drug Delivery System Sales (K Units) Forecast by Application (2021-2026)
Table 115. Global Transdermal/Transmucosal Drug Delivery System Revenue (Million US$) Forecast by Application (2021-2026)
Table 116. Global Transdermal/Transmucosal Drug Delivery System Sales (K Units) Forecast by Region (2021-2026)
Table 117. Global Transdermal/Transmucosal Drug Delivery System Sales Market Share Forecast by Region (2021-2026)
Table 118. Global Transdermal/Transmucosal Drug Delivery System Revenue Forecast by Region (2021-2026) (US$ Million)
Table 119. Global Transdermal/Transmucosal Drug Delivery System Revenue Market Share Forecast by Region (2021-2026)
Table 120. Research Programs/Design for This Report
Table 121. Key Data Information from Secondary Sources
Table 122. Key Data Information from Primary Sources
List of Figures
Figure 1. Picture of Transdermal/Transmucosal Drug Delivery System
Figure 2. Global Transdermal/Transmucosal Drug Delivery System Sales Market Share by Type: 2020 VS 2026
Figure 3. Transdermal Drug Delivery System Product Picture
Figure 4. Transmucosal Drug Delivery System Product Picture
Figure 5. Global Transdermal/Transmucosal Drug Delivery System Consumption Market Share by Application: 2020 VS 2026
Figure 6. Hospitals
Figure 7. Clinics
Figure 8. Others
Figure 9. Global Transdermal/Transmucosal Drug Delivery System Market Size 2015-2026 (US$ Million)
Figure 10. Global Transdermal/Transmucosal Drug Delivery System Sales Capacity (K Units) (2015-2026)
Figure 11. Global Transdermal/Transmucosal Drug Delivery System Market Size Market Share by Region: 2020 Versus 2026
Figure 12. Transdermal/Transmucosal Drug Delivery System Sales Share by Manufacturers in 2020
Figure 13. Global Transdermal/Transmucosal Drug Delivery System Revenue Share by Manufacturers in 2019
Figure 14. The Global 5 and 10 Largest Players: Market Share by Transdermal/Transmucosal Drug Delivery System Revenue in 2019
Figure 15. Transdermal/Transmucosal Drug Delivery System Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 16. Global Transdermal/Transmucosal Drug Delivery System Sales Market Share by Region (2015-2020)
Figure 17. Global Transdermal/Transmucosal Drug Delivery System Sales Market Share by Region in 2019
Figure 18. Global Transdermal/Transmucosal Drug Delivery System Revenue Market Share by Region (2015-2020)
Figure 19. Global Transdermal/Transmucosal Drug Delivery System Revenue Market Share by Region in 2019
Figure 20. North America Transdermal/Transmucosal Drug Delivery System Sales Market Share by Country in 2019
Figure 21. North America Transdermal/Transmucosal Drug Delivery System Revenue Market Share by Country in 2019
Figure 22. U.S. Transdermal/Transmucosal Drug Delivery System Sales Growth Rate (2015-2020) (K Units)
Figure 23. U.S. Transdermal/Transmucosal Drug Delivery System Revenue Growth Rate (2015-2020) (US$ Million)
Figure 24. Canada Transdermal/Transmucosal Drug Delivery System Sales Growth Rate (2015-2020) (K Units)
Figure 25. Canada Transdermal/Transmucosal Drug Delivery System Revenue Growth Rate (2015-2020) (US$ Million)
Figure 26. Europe Transdermal/Transmucosal Drug Delivery System Sales Market Share by Country in 2019
Figure 27. Europe Transdermal/Transmucosal Drug Delivery System Revenue Market Share by Country in 2019
Figure 28. Germany Transdermal/Transmucosal Drug Delivery System Sales Growth Rate (2015-2020) (K Units)
Figure 29. Germany Transdermal/Transmucosal Drug Delivery System Revenue Growth Rate (2015-2020) (US$ Million)
Figure 30. France Transdermal/Transmucosal Drug Delivery System Sales Growth Rate (2015-2020) (K Units)
Figure 31. France Transdermal/Transmucosal Drug Delivery System Revenue Growth Rate (2015-2020) (US$ Million)
Figure 32. U.K. Transdermal/Transmucosal Drug Delivery System Sales Growth Rate (2015-2020) (K Units)
Figure 33. U.K. Transdermal/Transmucosal Drug Delivery System Revenue Growth Rate (2015-2020) (US$ Million)
Figure 34. Italy Transdermal/Transmucosal Drug Delivery System Sales Growth Rate (2015-2020) (K Units)
Figure 35. Italy Transdermal/Transmucosal Drug Delivery System Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Russia Transdermal/Transmucosal Drug Delivery System Sales Growth Rate (2015-2020) (K Units)
Figure 37. Russia Transdermal/Transmucosal Drug Delivery System Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Asia Pacific Transdermal/Transmucosal Drug Delivery System Sales Market Share by Region in 2019
Figure 39. Asia Pacific Transdermal/Transmucosal Drug Delivery System Revenue Market Share by Region in 2019
Figure 40. China Transdermal/Transmucosal Drug Delivery System Sales Growth Rate (2015-2020) (K Units)
Figure 41. China Transdermal/Transmucosal Drug Delivery System Revenue Growth Rate (2015-2020) (US$ Million)
Figure 42. Japan Transdermal/Transmucosal Drug Delivery System Sales Growth Rate (2015-2020) (K Units)
Figure 43. Japan Transdermal/Transmucosal Drug Delivery System Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. South Korea Transdermal/Transmucosal Drug Delivery System Sales Growth Rate (2015-2020) (K Units)
Figure 45. South Korea Transdermal/Transmucosal Drug Delivery System Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. India Transdermal/Transmucosal Drug Delivery System Sales Growth Rate (2015-2020) (K Units)
Figure 47. India Transdermal/Transmucosal Drug Delivery System Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. Australia Transdermal/Transmucosal Drug Delivery System Sales Growth Rate (2015-2020) (K Units)
Figure 49. Australia Transdermal/Transmucosal Drug Delivery System Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Taiwan Transdermal/Transmucosal Drug Delivery System Sales Growth Rate (2015-2020) (K Units)
Figure 51. Taiwan Transdermal/Transmucosal Drug Delivery System Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Indonesia Transdermal/Transmucosal Drug Delivery System Sales Growth Rate (2015-2020) (K Units)
Figure 53. Indonesia Transdermal/Transmucosal Drug Delivery System Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Thailand Transdermal/Transmucosal Drug Delivery System Sales Growth Rate (2015-2020) (K Units)
Figure 55. Thailand Transdermal/Transmucosal Drug Delivery System Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Malaysia Transdermal/Transmucosal Drug Delivery System Sales Growth Rate (2015-2020) (K Units)
Figure 57. Malaysia Transdermal/Transmucosal Drug Delivery System Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Philippines Transdermal/Transmucosal Drug Delivery System Sales Growth Rate (2015-2020) (K Units)
Figure 59. Philippines Transdermal/Transmucosal Drug Delivery System Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Vietnam Transdermal/Transmucosal Drug Delivery System Sales Growth Rate (2015-2020) (K Units)
Figure 61. Vietnam Transdermal/Transmucosal Drug Delivery System Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Latin America Transdermal/Transmucosal Drug Delivery System Sales Market Share by Country in 2019
Figure 63. Latin America Transdermal/Transmucosal Drug Delivery System Revenue Market Share by Country in 2019
Figure 64. Mexico Transdermal/Transmucosal Drug Delivery System Sales Growth Rate (2015-2020) (K Units)
Figure 65. Mexico Transdermal/Transmucosal Drug Delivery System Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Brazil Transdermal/Transmucosal Drug Delivery System Sales Growth Rate (2015-2020) (K Units)
Figure 67. Brazil Transdermal/Transmucosal Drug Delivery System Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Argentina Transdermal/Transmucosal Drug Delivery System Sales Growth Rate (2015-2020) (K Units)
Figure 69. Argentina Transdermal/Transmucosal Drug Delivery System Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Middle East and Africa Transdermal/Transmucosal Drug Delivery System Sales Market Share by Country in 2019
Figure 71. Middle East and Africa Transdermal/Transmucosal Drug Delivery System Revenue Market Share by Country in 2019
Figure 72. Turkey Transdermal/Transmucosal Drug Delivery System Sales Growth Rate (2015-2020) (K Units)
Figure 73. Turkey Transdermal/Transmucosal Drug Delivery System Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Saudi Arabia Transdermal/Transmucosal Drug Delivery System Sales Growth Rate (2015-2020) (K Units)
Figure 75. Saudi Arabia Transdermal/Transmucosal Drug Delivery System Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. U.A.E Transdermal/Transmucosal Drug Delivery System Sales Growth Rate (2015-2020) (K Units)
Figure 77. U.A.E Transdermal/Transmucosal Drug Delivery System Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Sales Market Share of Transdermal/Transmucosal Drug Delivery System by Type (2015-2020)
Figure 79. Sales Market Share of Transdermal/Transmucosal Drug Delivery System by Type in 2019
Figure 80. Revenue Share of Transdermal/Transmucosal Drug Delivery System by Type (2015-2020)
Figure 81. Revenue Market Share of Transdermal/Transmucosal Drug Delivery System by Type in 2019
Figure 82. Global Transdermal/Transmucosal Drug Delivery System Sales Growth by Type (2015-2020) (K Units)
Figure 83. Global Transdermal/Transmucosal Drug Delivery System Sales Market Share by Application (2015-2020)
Figure 84. Global Transdermal/Transmucosal Drug Delivery System Sales Market Share by Application in 2019
Figure 85. Global Revenue Share of Transdermal/Transmucosal Drug Delivery System by Application (2015-2020)
Figure 86. Global Revenue Share of Transdermal/Transmucosal Drug Delivery System by Application in 2020
Figure 87. 3M Total Revenue (US$ Million): 2019 Compared with 2018
Figure 88. Antares Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 89. Aveva Drug Delivery Systems Total Revenue (US$ Million): 2019 Compared with 2018
Figure 90. Corium International Total Revenue (US$ Million): 2019 Compared with 2018
Figure 91. DURECT Total Revenue (US$ Million): 2019 Compared with 2018
Figure 92. Pantec Biosolutions Total Revenue (US$ Million): 2019 Compared with 2018
Figure 93. Tapemark Total Revenue (US$ Million): 2019 Compared with 2018
Figure 94. Tesa Labtec Total Revenue (US$ Million): 2019 Compared with 2018
Figure 95. Mylan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 96. Teva Total Revenue (US$ Million): 2019 Compared with 2018
Figure 97. Zosano Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 98. Price Trend of Key Raw Materials
Figure 99. Manufacturing Cost Structure of Transdermal/Transmucosal Drug Delivery System
Figure 100. Manufacturing Process Analysis of Transdermal/Transmucosal Drug Delivery System
Figure 101. Transdermal/Transmucosal Drug Delivery System Industrial Chain Analysis
Figure 102. Channels of Distribution
Figure 103. Distributors Profiles
Figure 104. Porter's Five Forces Analysis
Figure 105. North America Transdermal/Transmucosal Drug Delivery System Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 106. North America Transdermal/Transmucosal Drug Delivery System Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 107. Europe Transdermal/Transmucosal Drug Delivery System Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 108. Europe Transdermal/Transmucosal Drug Delivery System Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 109. Latin America Transdermal/Transmucosal Drug Delivery System Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 110. Latin America Transdermal/Transmucosal Drug Delivery System Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 111. Middle East and Africa Transdermal/Transmucosal Drug Delivery System Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 112. Middle East and Africa Transdermal/Transmucosal Drug Delivery System Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 113. Asia Pacific Transdermal/Transmucosal Drug Delivery System Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 114. Asia Pacific Transdermal/Transmucosal Drug Delivery System Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 115. Bottom-up and Top-down Approaches for This Report
Figure 116. Data Triangulation
Figure 117. Key Executives Interviewed
Keyplayers in Global Transdermal/Transmucosal Drug Delivery System Market Research Report 2020
3MAntares Pharma
Aveva Drug Delivery Systems
Corium International
DURECT
Pantec Biosolutions
Tapemark
Tesa Labtec
Mylan
Teva
Zosano Pharma
Request Sample
Request Discount
